2008
DOI: 10.14310/horm.2002.1206
|View full text |Cite
|
Sign up to set email alerts
|

Hypothalamic-pituitary-adrenal axis in patients with ankylosing spondylitis

Abstract: OBjeCTive: To investigate the hypothalamic-pituitary-adrenal (HPA) axis via the insulintolerance test (iTT), standard-dose (250 μg) ACTH test (SDT) and low-dose (1 μg) ACTH test (LDT) in patients with ankylosing spondylitis (AS). DeSiGN:The study group included 13 male patients with AS who were diagnosed according to the Modified New York criteria, and 8 healthy male subjects and was carried out at the Department of Physical Medicine and Rehabilitation, erciyes University Medical School. ACTH stimulation tests… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 19 publications
0
1
1
Order By: Relevance
“…The observation that the peak of osteocalcin and bAP precedes the cortisol peak could be interesting because cortisol appears to have an inhibitory effect on bone resorption in organ culture 49 . In contrast with findings in other inflammatory diseases such as RA and PMR, the present data indicate that there is no apparent abnormality of the HPA axis activity in AS 50,51 . This also might explain to some extent the respective lesser efficacy of glucocorticoids in seronegative spondyloarthropathies, in contrast to the outstanding therapeutic efficacy of glucocorticoids in PMR.…”
Section: Resultscontrasting
confidence: 99%
“…The observation that the peak of osteocalcin and bAP precedes the cortisol peak could be interesting because cortisol appears to have an inhibitory effect on bone resorption in organ culture 49 . In contrast with findings in other inflammatory diseases such as RA and PMR, the present data indicate that there is no apparent abnormality of the HPA axis activity in AS 50,51 . This also might explain to some extent the respective lesser efficacy of glucocorticoids in seronegative spondyloarthropathies, in contrast to the outstanding therapeutic efficacy of glucocorticoids in PMR.…”
Section: Resultscontrasting
confidence: 99%
“…In this study, we hypothesized that CD244 reduces the risk of A by up-regulating 1-stearoyl-GPE (18:0) levels and down-regulating 1-(1enyl-stearoyl)-GPE (p-18:0) levels.1. Furthermore, studies such as Imrich R and Kirnap M showed that no signi cant difference in Cortisol levels was seen in AS patients compared to healthy controls [43,44] .…”
Section: Discussionmentioning
confidence: 98%